Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Patara Pharma (United States) | Researchclopedia

Back to institutions

Patara Pharma (United States)

San Diego, Californiacompany

66

Works

2,128

Citations

28

h-index

Top Research Topics

Diabetes Treatment and Management Diabetes Management and Research Pancreatic function and diabetes

Top Researchers

Jilly F. Evans Pulmonary and Allergy Associates

142 works16,032 citationsh-index: 52

Recent Research

Optimal Dosage Regimen of Grammidin® with Anesthetic in the Treatment of Acute Infectious Inflammatory Conditions of the Pharynx

O. V. Karneeva,A. V. Gurov,et al.

20260 citations

Respiratory and Cough-Related Research

Dermatology and Skin Diseases

Acne and Rosacea Treatments and Effects

Bladder and Urothelial Cancer Treatments

Sphingolipid Metabolism and Signaling

Metabolism, Diabetes, and Cancer

Pharmacology and Obesity Treatment

Pain Mechanisms and Treatments

Helicobacter pylori-related gastroenterology studies

Arthur A. Levin Genomics Institute of the Novartis Research Foundation

197 works11,070 citationsh-index: 49

Jiali Han Indiana University Health

222 works9,561 citationsh-index: 53

Lu Shen Ministry of Education of the People's Republic of China

470 works9,374 citationsh-index: 49

George H. Kraft Patara Pharma (United States)

282 works7,432 citationsh-index: 49

Xin Li Nanjing Agricultural University

259 works7,190 citationsh-index: 43

Pharmacokinetic and safety comparison of two dosage strengths of the drug Ranquilon®: a bioequivalence study

V. B. Vasilyuk,S. A. Sinyavin,et al.

20260 citations

A novel cabozantinib formulation with reduced pharmacokinetic variability and the potential to improve safety in patients with renal cell carcinoma.

Jaymes S. Holland,John Duan,et al.

20260 citations

ADVANCED-2: Interim efficacy and safety data in BCG-unresponsive participants with high-grade non-muscle invasive bladder cancer.

Raj Satkunasivam,Timothy D. Lyon,et al.

20260 citations

Interim safety and tolerability of TARA-002 in patients with BCG-naïve and unresponsive high-grade non-muscle invasive bladder cancer in ADVANCED-2.

Timothy N. Clinton,Timothy D. Lyon,et al.

20260 citations

Study of the Pharmacokinetics, Tolerability, and Safety of Fixed-Dose Combinations of Gramicidin S and Cetylpyridinium Chloride

V. A. Dedkova,A. M. Bartsits,et al.

20250 citations